ICER Outlines Planned Review of High Cholesterol Treatments
Sydney Otomancek2023-11-15T16:52:59-05:00July 7th, 2020|Categories: Featured, HEOR Feature, Industry News|Tags: Healtheconomics.com, HEOR, High Cholesterol, ICER, inclisiran, Institute for Clinical and Economic Review, Nexletol, Nexlizet|
The Institute for Clinical and Economic Review (ICER) in a recently-released document outlines its planned review of high cholesterol treatments. [...]
ICER Plans Review of Treatments for High Cholesterol
Sydney Otomancek2023-11-15T16:53:38-05:00June 12th, 2020|Categories: Featured, Industry News|Tags: Esperion Therapeutics, Healtheconomics.com, HEOR, High Cholesterol, ICER, inclisiran, Institute for Clinical and Economic Review, Nexletol, Novartis|
The Institute for Clinical and Economic Review (ICER) announced plans to review Novartis' inclisiran and Esperion Therapeutics' Nexletol for the [...]
Receive essential insights, resources and content direct to your inbox!
Hit subscribe to stay informed!